JUL 27, 2015 1:31 PM PDT

Protein Imbalance Can Cause Cancer

WRITTEN BY: Ilene Schneider
While most scientists have viewed genetic aberrations as the primary cause of almost all cancer, a new study of ovarian cancer at the University of Leeds in the United Kingdom and the University of Texas MD Anderson Cancer Center suggests that cancer may be caused "solely by protein imbalances within cells." Published in the journal Oncogene and reported in Science Daily, the research shows how "protein imbalance is a powerful prognostic tool, indicating whether or not patients are likely to respond to chemotherapy and whether a tumor is likely to spread to other sites." This study could also lead to new therapies designed to measure and prevent dangerous protein imbalances in cells, the article explains (http://www.sciencedaily.com/releases/2015/07/150727092537.htm).
Cancer can have non-genetic causes.
According to the American Cancer Society, cancer, the second most common cause of death in the US, accounts for nearly one of every four deaths. The World Health Organization estimates that, worldwide, there were 4 million new cancer cases and 8.2 million cancer-related deaths in 2012 (http://www.medicalnewstoday.com/info/cancer-oncology/).

According to the lead author, Professor John Ladbury, Dean of the University of Leeds' Faculty of Biological Sciences and Professor of Mechanistic Biology, "There has been huge investment in sequencing the human genome with the idea that if we get all the relevant genetic information we can predict whether you have a predisposition to cancer and, ultimately, use a precision medicine-based approach to develop a therapeutic approach. Our study demonstrates that genetic screening alone is not enough."

The study concentrated on the "Akt pathway," a signaling pathway inside cells that drives cancer formation and the spread of cancers through the body. Normally, the cell would get external signals by means of a cell wall-bound receptor (FGFR2, in this research). Because of this stimulus, the receptor becomes "switched on" inside the cell, thus triggering the recruitment of signaling proteins and the initiation of the Akt pathway, which has the function of getting the cell to proliferate. According to the article, "In some cancerous cells, this pathway is permanently switched on. A conventional approach to diagnosing this cancer would be to look for genetic modification of the receptor (or recruited proteins), which could be responsible for maintaining the switched on state."

The researchers studied isolated cancer cells that did not have external stimulation and determined that the "Akt pathway" could be set in motion without genetic modifications. They found that two proteins -- Plc?1 and Grb2 -- compete for attaching to FGFR2. The relative concentration of these proteins determines which one does the binding. When Plc?1 succeeds, it stimulates the Akt pathway. Thus, an imbalance in the amount of the two proteins can trigger cell replication and cancer formation.

Now the researchers are studying the same mechanisms in other kinds of cancer. In addition, they are looking at other cell receptors that might play a role in sustaining oncogenic signaling without being activated.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
FEB 10, 2021
Drug Discovery & Development
Black Men Respond Best to Immunotherapy for Prostate Cancer
FEB 10, 2021
Black Men Respond Best to Immunotherapy for Prostate Cancer
Researchers from Northwestern University have found that Black men and men of African ancestry respond better than men f ...
FEB 17, 2021
Clinical & Molecular DX
Urine Test Bypasses the Need for Prostate Biopsies
FEB 17, 2021
Urine Test Bypasses the Need for Prostate Biopsies
Researchers have created a urine test for prostate cancer that could make unnecessary biopsies a thing of the past. The ...
FEB 14, 2021
Cancer
Your daily commute exposes you to these two carcinogens
FEB 14, 2021
Your daily commute exposes you to these two carcinogens
New research from UC Riverside reports alarming findings on the risks of exposure to carcinogenic chemicals from time sp ...
MAR 04, 2021
Clinical & Molecular DX
Is the Cancer Treatment Working? Liquid Biopsies Provide Answers.
MAR 04, 2021
Is the Cancer Treatment Working? Liquid Biopsies Provide Answers.
A newly-developed tool could help physicians monitor the performance of colorectal cancer therapies simply by examining ...
MAR 09, 2021
Cannabis Sciences
Cannabis Alleviates Neuropathic Pain from Chemotherapy
MAR 09, 2021
Cannabis Alleviates Neuropathic Pain from Chemotherapy
Neuropathic pain from oxaliplatin-based chemotherapy regimens occurs in up to 90% of patients, and continued exposure to ...
APR 05, 2021
Cancer
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
APR 05, 2021
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
A team from the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center is introdu ...
Loading Comments...